Anja Gackler

Essen, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Safety and efficacy of rituximab-free ABO incompatible kidney transplantation: a German multicenter cohort study.

Safety and efficacy of rituximab-free ABO incompatible kidney transplantation: a German multicenter cohort study.

Journal: Frontiers in nephrology

Published: June 03, 2026

Revisiting clinical response and refractoriness in immune thrombotic thrombocytopenic purpura.

Revisiting clinical response and refractoriness in immune thrombotic thrombocytopenic purpura.

Journal: Blood

Published: October 14, 2025

Revisiting Clinical Response and Refractoriness in Immune Thrombotic Thrombocytopenic Purpura.

Revisiting Clinical Response and Refractoriness in Immune Thrombotic Thrombocytopenic Purpura.

Journal: Blood

Published: October 14, 2025

Genetic variants of the HLA-G/LILRB1 ligand-receptor axis in donors or recipients are prognostic covariates for rejection after living kidney transplantation.

Genetic variants of the HLA-G/LILRB1 ligand-receptor axis in donors or recipients are prognostic covariates for rejection after living kidney transplantation.

Journal: Frontiers in immunology

Published: September 02, 2025

Dickkopf 3 - A novel biomarker for chronic kidney disease and its progression in people living with HIV?

Dickkopf 3 - A novel biomarker for chronic kidney disease and its progression in people living with HIV?

Journal: International journal of STD & AIDS

Published: July 28, 2025

Transition in nephrology

Transition in nephrology

Journal: Innere Medizin (Heidelberg, Germany)

Published: May 13, 2025

Living with Chronic Kidney Disease and Kidney Transplantation During COVID-19: A Study of Psychological and Behavioral Impacts.

Living with Chronic Kidney Disease and Kidney Transplantation During COVID-19: A Study of Psychological and Behavioral Impacts.

Journal: Healthcare (Basel, Switzerland)

Published: April 27, 2025

Impact of the Melanocortin-4 Receptor Agonist Setmelanotide on MASLD and Kidney Function in Bardet-Biedl Syndrome.

Impact of the Melanocortin-4 Receptor Agonist Setmelanotide on MASLD and Kidney Function in Bardet-Biedl Syndrome.

Journal: The Journal of clinical endocrinology and metabolism

Published: April 25, 2025

Patient and caregiver experiences with a patient-support program for setmelanotide treatment of patients with Bardet-Biedl syndrome.

Patient and caregiver experiences with a patient-support program for setmelanotide treatment of patients with Bardet-Biedl syndrome.

Journal: Orphanet journal of rare diseases

Published: April 09, 2025

Effectiveness and Safety of Switching to Ravulizumab From Eculizumab in Kidney Transplant Recipients With Atypical Hemolytic Uremic Syndrome: A Global aHUS Registry Analysis.

Effectiveness and Safety of Switching to Ravulizumab From Eculizumab in Kidney Transplant Recipients With Atypical Hemolytic Uremic Syndrome: A Global aHUS Registry Analysis.

Journal: Clinical transplantation

Published: March 27, 2025

Atypical hemolytic uremic syndrome: differential diagnosis and therapy - A clinical practice guideline for diagnosis and therapy

Atypical hemolytic uremic syndrome: differential diagnosis and therapy - A clinical practice guideline for diagnosis and therapy

Journal: Deutsche medizinische Wochenschrift (1946)

Published: January 29, 2025

Extracorporeal myoglobin elimination using the adsorber CytoSorb or the high-flux HF80 dialyzer for patients with severe rhabdomyolysis: a comparative study.

Extracorporeal myoglobin elimination using the adsorber CytoSorb or the high-flux HF80 dialyzer for patients with severe rhabdomyolysis: a comparative study.

Journal: Clinical kidney journal

Published: January 12, 2025

Showing 1-12 of 54

Last Updated: 09/26/2026